HanchorBio Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-497.62	-1,354	-591.36	-446.32
Depreciation & Amortization	37.47	36.28	33.04	26.12
Other Amortization	1.15	1.12	0.84	0.75
Loss (Gain) From Sale of Investments	-0	-1.12	-0.94	-1.13
Stock-Based Compensation	22.25	311.96	47.9	37.33
Other Operating Activities	115.37	399.21	62.51	-81.63
Change in Accounts Receivable	-4.61	-1.31	0.05	2.29
Change in Accounts Payable	28.29	1.72	14.52	124.77
Change in Other Net Operating Assets	4.37	-0.56	-6.15	0.22
Operating Cash Flow	-293.33	-606.79	-439.59	-337.62
Capital Expenditures	-14.76	-18.78	-22.04	-70.78
Sale (Purchase) of Intangibles	-0.29	-0.19	-1.14	-
Investment in Securities	-16.23	76.36	-87.71	1.13
Investing Cash Flow	-30.21	57.39	-110.9	-69.65
Short-Term Debt Issued	-	26.24	29.69	-
Long-Term Debt Issued	-	-	-	20
Total Debt Issued	-2.71	26.24	29.69	20
Short-Term Debt Repaid	-	-30.47	-	-
Long-Term Debt Repaid	-	-20.1	-20.07	-11.39
Total Debt Repaid	-35.98	-50.57	-20.07	-11.39
Net Debt Issued (Repaid)	-38.69	-24.33	9.62	8.61
Issuance of Common Stock	814	120.08	-	-
Other Financing Activities	209.54	509.22	635.6	491.09
Financing Cash Flow	984.78	604.98	645.22	499.7
Foreign Exchange Rate Adjustments	-7.94	8.05	1.05	12.53
Net Cash Flow	653.3	63.63	95.78	104.97
Free Cash Flow	-308.09	-625.57	-461.63	-408.39
Free Cash Flow Margin	-98.68%	-	-	-12143.74%
Free Cash Flow Per Share	-2.74	-9.41	-8.87	-9.23
Cash Interest Paid	4.47	4.9	2.74	2.5
Levered Free Cash Flow	-	-179.45	-296.65	-
Unlevered Free Cash Flow	-	-176.39	-294.92	-
Change in Working Capital	28.05	-0.15	8.42	127.28

Source: S&P Capital IQ. Standard template. Financial Sources.